Securities and Exchange Commission v. Teren S. Peizer et al

  1. January 09, 2024

    DOJ Can't 'Salvage' Novel Insider Trading Case, Exec Says

    The former healthcare CEO at the center of a novel insider trading indictment has moved to dismiss the criminal charges against him, arguing prosecutors failed to allege that shareholders were kept in the dark about a faltering customer relationship while the executive prepared to sell off millions of dollars worth of stock.

  2. March 06, 2023

    DOJ Cautions Execs With Novel Insider Trading Case

    An insider trading indictment against a CEO that the U.S. Department of Justice has hailed as "groundbreaking" may have meant to serve as a warning to executives leaning on so-called 10b5-1 trading plans to stay out of trouble, but it's unlikely to lead to a flood of similar prosecutions, experts told Law360.

  3. March 01, 2023

    Health Care CEO Hit With Novel Insider Trading Indictment

    Federal prosecutors in California announced Wednesday that they've filed the first ever criminal case based exclusively on an executive's use of so-called Rule 10b5-1 trading plans, accusing the CEO of a publicly traded health care company of using his knowledge of a souring customer relationship to avoid $12.7 million in stock market losses.